Page last updated: 2024-12-06

ethanolamine o-sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Ethanolamine O-sulfate (EOS) is a naturally occurring compound found in various biological systems. It is a sulfated derivative of ethanolamine, a simple amino alcohol, and is known for its role in various physiological processes. EOS has been studied extensively in the context of neurotransmission, inflammation, and cancer.

One significant aspect of EOS is its involvement in the regulation of neurotransmitter levels. Research suggests that EOS can influence the release of neurotransmitters like acetylcholine and glutamate. This modulation of neurotransmission can have implications for neuronal function and behavior.

EOS also plays a role in the inflammatory response. Studies have shown that EOS can influence the production of pro-inflammatory cytokines, potentially impacting the severity and duration of inflammation.

In addition to its roles in neurotransmission and inflammation, EOS has been linked to cancer development. Research suggests that EOS may act as a tumor suppressor, inhibiting the growth of cancer cells.

The synthesis of EOS occurs through the enzymatic sulfation of ethanolamine. This process is catalyzed by sulfotransferases, a family of enzymes that play a crucial role in the metabolism of various molecules.

The multifaceted nature of EOS, involving its involvement in neurotransmission, inflammation, and potential cancer-related activity, makes it a subject of ongoing research. Understanding the role of EOS in these processes could lead to the development of novel therapeutic strategies for a variety of conditions.'

Cross-References

ID SourceID
PubMed CID70223
CHEMBL ID341858
SCHEMBL ID222524
MeSH IDM0074503

Synonyms (63)

Synonym
nsc3532
EOS ,
nsc-3532
mono(2-aminoethyl) sulfate
926-39-6
ethanol, hydrogen sulfate (ester)
ethanolamine o-sulfate
2-aminoethyl hydrogen sulfate
2-aminoethyl sulfate
nsc-204188
nsc204188
aminoethyl sulfate
2-aminoethyl hydrogen sulphate
nsc 3532
2-aminoethanol, hydrogen sulfate (ester)
ai3-16953
c2h7no4s
nsc 204188
einecs 213-135-7
ethanol, 2-amino-, hydrogen sulfate (ester)
was-34
2-aminoethyl hydrogen sulfate, >=98.0% (t)
CHEMBL341858 ,
wsyuevramdsjkl-uhfffaoysa-
inchi=1/c2h7no4s/c3-1-2-7-8(4,5)6/h1-3h2,(h,4,5,6)
sulfuric acid mono(2-aminoethyl) ester
bdbm50281574
sulfuric acid mono-(2-amino-ethyl) ester
dtxsid3044469 ,
NCGC00255868-01
cas-926-39-6
tox21_302045
dtxcid1024469
sulfuric acid mono 2-aminoethylester
AKOS005216612
9c8f910hlk ,
unii-9c8f910hlk
ethanol, 2-amino-, 1-(hydrogen sulfate)
FT-0611246
SCHEMBL222524
ethanolamine sulfate
2-aminoethyl sulfuric acid
aminoethyl sulfate [inci]
ethanol, 2-amino-, hydrogen sulfate
2-aminoethyl hydrogensulfate
sulphuric acid mono-(2-aminoethyl)ester
sulphuric acid mono-2-amino-ethyl ester
2-aminoethylhydrogensulfate
ethanolamine-o-sulphate
Q-101293
2-aminoethyl hyorogen sulfate
F0001-2229
mfcd00008179
CS-0059227
Q5403035
DS-15965
2-aminoethanol sulfate
STL183260
D71117
A860009
(2-aminoethoxy)sulfonic acid
EN300-81510
2-azanylethyl hydrogen sulfate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In addition, open-field activity and body temperature were reliably lowered as a function of dosage while catalepsy was increased."( Effects of lateral hypothalamic lesions on the anorexia induced by ethanolamine-O-sulfate.
Coscina, DV; Nobrega, JN, 1989
)
0.28
" Oral dosing [3 mg/ml of drinking water, giving doses of GVG of 194 +/- 38 mg/kg/day and of EOS of 303 +/- 42 mg/kg/day (mean +/- SD)] was followed by microdialysis at 2, 8, and 21 days."( The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.
Fowler, LJ; Qume, M; Whitton, PS, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency4.36410.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (79.03)18.7374
1990's12 (19.35)18.2507
2000's1 (1.61)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.44 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index3.96 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.61%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (98.39%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]